Catena Bio is a startup based in the United States, 1 tracked investor.
Catena Bio is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Catena Bio develops a proprietary platform enabling the creation of multi-payload antibody-drug conjugates with enhanced stability and therapeutic potential, primarily targeting solid tumors.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.